Pancreatic cancer is recognized as a highly aggressive form of cancer that presents significant diagnostic challenges. During the “Health First” podcast, supported by United Hospital, oncologist Ilir Kurtishi highlighted that a primary difficulty in managing the disease is its tendency to lack clear symptoms during the early stages. Kurtishi noted that the condition is frequently diagnosed late, resulting in many patients presenting when the cancer is already in advanced stages, which complicates treatment options.
Furthermore, the anatomical location of the pancreas contributes to the diagnostic hurdles. As tumors can develop over extended periods without causing noticeable symptoms, early detection remains difficult. This combination of subtle initial signs and the organ’s placement makes timely intervention challenging.
The discussion also touched upon advancements in treatment, referencing a new drug developed for pancreatic cancer. Overall, the consensus among experts, as articulated by Kurtishi, emphasizes the critical need for improved screening and awareness to address the issue of late-stage diagnosis, which significantly impacts patient outcomes for this aggressive form of cancer.
Topics: #cancer #pancreatic #late
